Jiangsu Nhwa Pharmaceutical Co Ltd (SZSE:002262) Share Price

Company Profile

Business description
Jiangsu Nhwa Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in the manufacturing of APIs and dosages. The company markets its pharmaceutical products in four main categories: anesthetic drugs, such as midazolam injection and etomidate fat emulsion injection; psychiatric drugs, including risperidone tablets and related products; neurological drugs, such as gabapentin capsules; and bulk pharmaceuticals, including fenofibrate and miconazole nitrate. In addition, the company is also involved in the pharmaceuticals trading business.
Contact
No. 31, Longhu West Road
Enhua Technology Building
Economic and Technological Development Zone
Xuzhou221009
CHN
T: +86 51687767115
https://www.nhwa-group.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
6,003

Recommended

Aussie stock exchange remains materially undervalued despite growing cost concerns.

Roy Van Keulen | 29 May 2026

Questions surround Australia’s largest data center developer and its growing pipeline.

Yingqi Tan, CFA | 29 May 2026

The e-commerce business continues its sales momentum despite challenging backdrop.

Johannes Faul, CFA | 28 May 2026

Index	Last price	Change	% Change
All Ordinaries	8,965.00	77.80	0.88%
CAC 40	8,183.34	5.53	-0.07%
DAX 40	25,104.70	12.45	0.05%
Dow JONES (US)	50,986.07	317.10	0.63%
FTSE 100	10,409.28	16.68	-0.16%
HKSE	25,182.39	176.23	0.70%
NASDAQ	26,994.89	77.42	0.29%
Nikkei 225	66,329.50	1,636.38	2.53%
NZX 50 Index	13,244.55	38.44	0.29%
S&P 500	7,585.08	21.45	0.28%
S&P/ASX 200	8,731.70	73.10	0.84%
SSE Composite Index	4,068.57	30.07	-0.73%